News | April 26, 2024
Laurus Labs posts Q4 FY24 consolidated PAT at Rs. 75.61 Cr
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Laurus Labs has reported total income of Rs. 1,458.20 crores during the period ended March 31, 2024
Syngene International has reported total income of Rs. 933 crores during the period ended March 31, 2024
International Business is expected to register double-digit growth in constant currency terms
Net product sales in the fourth quarter of 2023 include the recognition of $0.6 billion from deferred revenue, related to Gavi, the Vaccine Alliance
The company has reported total income of Rs. 1682.45 crores during the period ended March 31, 2023
Two patents were filed during the quarter ended 31st March, 2023 and the cumulative filings till date are 3239
US formulations revenue increased by 11.6% YoY to Rs. 3,045 crore and Europe formulation revenue stood at Rs. 1,660 crore
The company has reported total income of Rs. 11303.95 crores during the period ended March 31, 2023
The company has reported total income of Rs. 3276.35 crores during the period ended March 31, 2023
The company has reported total income of Rs. 880.59 crores during the period ended March 31, 2023
Subscribe To Our Newsletter & Stay Updated
